R & D

HUMASIS INSTITUTE is a global leading manufacturer for development of immuno-chromatography assay and medical equipment with global competitiveness since 2003 when was designated as our research center. The research team performed to introduce over 80 kinds of in-vitro immuno-chromatography assays in fertility hormones, infectious diseases, tumor markers, cardiac markers, and bioterror materials for our worldwide customers while continuously launching new products under ISO certified quality system.

We strive to develop and pave the way for future technologies of rapid diagnosis tests combining u-healthcare and mobile healthcare system POCT analyzer using high sensitivity probe and sensor technology that focuses on research and developing.

Core Technology

HUMASIS Pipeline

Product Category Markers Test Method
Cardiovascular disease FABP Rapid test, quantitative, qualitative, Reader
FABP-Tnl Duo Rapid test, quantitative, qualitative, Reader
D-Dimer Rapid test, quantitative, Reader
Tumor marker AFP Rapid test, quantitative, Reader
CEA Rapid test, quantitative, Reader
Infectious disease CRP Rapid test, quantitative, Reader
G6PD Rapid test, quantitative, Reader
pLDH Rapid test, quantitative, Reader
Procalcitonin Rapid test, quantitative, Reader
Endocrine disease LH/FSH Rapid test, quantitative, Reader
TSH Rapid test, quantitative, Reader
T3/T4 Rapid test, quantitative, Reader
Testosteron Rapid test, quantitative, Reader